Nutrigenomics and Cancer Prevention by Nepomuceno, Júlio César
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 17
Nutrigenomics and Cancer Prevention
Júlio César Nepomuceno
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/55429
1. Introduction
Cancer is fundamentally a genetic disease. At the beginning of the process is an alteration in the
DNA of a single cell. This change in DNA can be caused by several factors, chemical, physical
or biological phenomena. The stage of promotion is the second stage of carcinogenesis. The
genetically altered cells, ie, "initiated," suffer the effects of carcinogens classified as oncopromo‐
tores. The initiated cell is transformed into a malignant cell, a slow and gradual process. For this
transformation to occur, you need a long and continuous contact with the carcinogen promot‐
er. The stage of progression is the third and final stage and is characterized by uncontrolled
proliferation of cells and irreversibly changed. At this stage cancer is already installed, progress‐
ing to the emergence of the first clinical manifestations of the disease [1]. In this sense, the diet
plays a key role in various stages of cancer development. The process of carcinogenesis may be
affected by nutritional factors through mechanisms that promote or inhibit its development.
Some foods can contain not only carcinogens, but also other substances that act to reduce the
damage to the cell's genetic material caused by environmental mutagens. The observation of
cancer in an individual does not identify the causative agent(s). However, epidemiological data
on populations do indicate that a large fraction of human cancers are associated with lifestyle/
diet. Such studies may also help identify the etiologic agents but unless there are good dose-
response data for humans and/or animal models, the probability of identifying the agent is not
high. Cancers may result from endogenous reactions, such as oxidations or from exogenous
agents, such as tobacco smoke (lung cancer), sunlight exposure (skin cancer), aflatoxin (liver
cancer), and relatively high doses of ionizing radiations (many types of cancers) [2].
The importance of nutrition in health is not a new idea. More than two thousand years ago,
Hippocrates, the father of Western medicine, wrote: "Let food be thy medicine and medicine
be thy food." What has changed since the time of Hippocrates is our understanding of the
details of how nutrition affects our health. Researchers are getting more knowledge as to what
foods or bioactive food compounds and how they can interact with our bodies promoting
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health. The Human Genome Project was one of the key factors that enable the study of gene-
food interactions and promotion of health. Discoveries in genetics make it possible to under‐
stand the effects of nutrients in processes at the molecular level in the body and also the variable
effects of dietary components on each individual. Research has shown that the nutrients affect
gene expression and formation of several proteins that are important in the formation and
maintenance of tissues. So, faced with this interaction genomics and nutrition, emerges
Nutrigenomics aiming to understand the functions of all genes and their interactions with
food, in order to promote health and reduce the risk of developing diseases [3].
Nutrigenomics studies the modulating effect of the chemical compounds in foods and on the
stability of DNA synthesis and gene expression. The nutrients are able to affect the genome
and its expression through the synthesis of nucleotides, prevention and repair of DNA damage,
or through epigenetic mechanisms including methylation of histones, proteins responsible for
chromatin structure that play an important role in regulating gene expression. Those meth‐
odological approaches are based on nutrition, molecular biology, and genomics. Integration
of these disciplines is leading to identification and understanding of individual and population
differences and similarities in gene expression, or phenotype, in response to diet. We can
consider nutrigenomics as a multidisciplinary science that applies the genomic techniques
besides the biochemical and epidemiological aspects, with the aim to understand the etiologic
aspects of chronic diseases such as cardiovascular diseases, diabetes, obesity and cancer [4].
An understanding of scientific information about the composition and functions of genomes,
has created unprecedented opportunities for increasing our understanding of how nutrients
modulate gene and protein expression and ultimately influence cellular and organismal
metabolism. On that basis, the purpose of this chapter is to make a broad review study to
evaluate the modulation between compounds found in nutrients and their interactions with
on the genomic stability and control of gene expression.
2. Nutrition and epigenetics
All the cells in the body have identical genomes. However, each cell has one of many “epige‐
nomes”, unique sets of epigenetic instructions for establishing and maintaining lineage-
specific expression profiles. The genome is programmed to express appropriate sets of genes,
in particular tissues, at specific time points during the individual’s life. Epigenetic events create
a memory of cell identity, maintaining genomic functions such as the maintenance of cell
identity after differentiation, the propagation of essential features of chromosomal architecture
and dosage compensation [5]. Epigenetic mechanisms are capable of modulating gene
expression through changes in the chromosomes structure. Chromosomes are formed from
the condensation of the chromatin, which is formed by a complex of DNA, and unique proteins
called histone. Examples of epigenetic mechanisms may be mentioned as DNA methylation
and histone acetylation [3].
DNA methylation occurs at the cytosine bases of eukaryotic DNA, which are converted to 5-
methylcytosine. The altered cytosine residues are usually immediately adjacent to a guanine
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nucleotide, resulting in two methylated cytosine residues sitting diagonally to each other on
opposing DNA strands [6]. DNA methylation, which modifies a cytosine base at the CpG
dinucleotide residues with methyl groups, is catalyzed by DNA methyltransferases (Dnmt)
and regulates gene expression patterns by altering chromatin structures. Currently, 5 different
Dnmt are known: Dnmt1, Dnmt2, Dnmt 3a, Dnmt3b and DnmtL [7]. The Polycomb group
protein EZH2 directly controls DNA methylation (Figure 1). EZH2 serves as a recruitment
platform for DNA methyltransferases, thus highlighting a previously unrecognized direct
connection between two key epigenetic repression systems [8].
Figure 1. Polycomb Group (PcG) protein EZH2 serves as a recruitment platform for DNA methyltransferases (http://
www.ulb.ac.be/medecine/fukslab/research.htm).
DNA methylation is essential for cell differentiation and embryonic development. Moreover,
in some cases, methylation has observed to play a role in mediating gene expression. In
mammals, methylation is found sparsely but globally, distributed in definite CpG sequences
throughout the entire genome, with the exception of CpG islands, or certain stretches (ap‐
proximately 1 kilobase in length) where high CpG contents are found. The methylation of these
sequences can lead to inappropriate gene silencing, such as the silencing of tumor suppressor
genes in cancer cells [6]. A large amount of research on DNA methylation and disease has
focused on cancer and tumor suppressor genes. Tumor suppressor genes are often silenced in
cancer cells due to hypermethylation. In contrast, the genomes of cancer cells have been shown
to be hypomethylated overall when compared to normal cells, with the exception of hyper‐
methylation events at genes involved in cell cycle regulation, tumor cell invasion, DNA repair,
and other events in which silencing propagates metastasis. In fact, in certain cancers, such as
that of the colon, hypermethylation is detectable early and might serve as a biomarker for the
disease [6] (See Figure 2).
In the nutritional field, epigenetics is exceptionally important, because nutrients and bioactive
food components can modify epigenetic phenomena and alter the expression of genes at the
transcriptional level. Nutrients can reverse or change epigenetic phenomena such as DNA
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methylation and histone modifications, thereby modifying the expression of critical genes
associated with physiologic and pathologic processes, including embryonic development,
aging, and carcinogenesis [7].
The most interesting study linking diet and epigenetics was made by Kucharski et al. [10],
about nutritional control of reproductive status in honeybees via DNA methylation. Fertile
queens and sterile workers are alternative forms of the adult female honeybee that develop
from genetically identical larvae following differential feeding with royal jelly. Royal jelly is a
complex, protein-rich substance secreted from glands on the heads of worker bees. A larva
destined to become a queen is fed large quantities of royal jelly inside a specially constructed
compartment called a queen cup. The authors observed that larvae fed with royal jelly
developed functional ovaries and a larger abdomen for egg laying, while worker bees remain
sterile. She'll also develop the necessary behaviors to act as queen, such as killing rival queens,
making communication sounds known as "piping," and going on "mating flights." The queen
is fed royal honey exclusively for the rest of her life. They showed that royal jelly silences a
key gene (Dnmt3), which codes for an enzyme involved in genome-wide gene silencing. When
Dnmt3 is active in bee larvae, the queen genes are epigenetically silenced and the larvae
develop into the default "worker" variety. But when royal jelly turns Dnmt3 off, certain genes
jump into action that turn the lucky larvae into queens. The authors suggested that DNA
Figure 2. DNA methylation and cancer. This diagram shows a representative region of genomic DNA in a normal cell.
The region contains repeat-rich, hypermethylated pericentromeric heterochromatin and an actively transcribed tumor
suppressor gene (TSG) associated with a hypomethylated CpG island (indicated in red). In tumor cells, repeat-rich het‐
erochromatin becomes hypomethylated, and this contributes to genomic instability (a hallmark of tumor cells)
through increased mitotic recombination events. De novo methylation of CpG islands also occurs in cancer cells, and it
can result in the transcriptional silencing of growth-regulatory genes. These changes in methylation are early events in
tumorigenesis. (See reference [9].)
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methylation in Apis is used for storing epigenetic information, that the use of that information
can be differentially altered by nutritional input, and that the flexibility of epigenetic modifi‐
cations underpins, profound shifts in developmental fates, with massive implications for
reproductive and behavioral status.
During our lifetime, nutrients can modify physiologic and pathologic processes through
epigenetic mechanisms that are critical for gene expression (summarized in Table 1). Modu‐
lation of these processes through diet or specific nutrients may prevent diseases and maintain
health. However, it is very hard to delineate the precise effect of nutrients or bioactive food
components on each epigenetic modulation and their associations with physiologic and
pathologic processes in our body, because the nutrients also interact with genes, other
nutrients, and other lifestyle factors. Furthermore, each epigenetic phenomenon also interacts
with the others, adding to the complexity of the system [7].
Nutrient or diet Epigenetic mechanism
Embryonic Folate DNA methylation, imprinting
development
Choline DNA methylation
Protein restriction DNA methylation, histone
modifications
Alcohol DNA methylation
Stem cell Butyrate Histone acetylation, DNA
methylation
Retinoic acid PRC
Aging Folate DNA methylation
Calorie restriction Histone acetylation
Immune function Folate DNA methylation
Cancer Methyl-deficient diet Histone modification, microRNA
Genistein DNA methylation, microRNA
(-)-Epigallocatechin-3-gallate DNA methylation, PRC
Curcumin microRNA
Obesity, insulin High-fat diet DNA methylation, microRNA
resistance
Methyl-deficient diet DNA methylation
Curcumin Histone acetylation
Inflammation Resveratrol Histone acetylation
AdoMet Histone methylation
Methyl-deficient diet microRNA
Neurocognition Choline DNA methylation, histone
methylation
Data in reference [7].
Table 1. Epigenetic roles of nutrition in physiologic and pathologic processes
Nutrigenomics and Cancer Prevention
http://dx.doi.org/10.5772/55429
395
2.1. Diet and genomic stability
Eukaryotic DNA replication starts at multiple sites throughout the genome and is necessarily
coordinated with transcription, sister chromatid cohesion, nucleosome assembly and cell cycle
progression. In addition to the complexity of the replication reaction it, during replication cells
need to deal with DNA damage and stalled forks, originated inevitably by the action of
exogenous and endogenous agents. The success of this process is crucial to preserve genome
stability, and the inability to deal with DNA lesions during replication or to protect or restart
stalled forks leads to DNA breaks, chromosomal rearrangements, and mutations that can cause
the loss of cell viability, but in addition errors in DNA replication result in a large number of
human syndromes, including premature aging, various cancer predispositions and genetic
abnormalities. To solve or reduce these problems, cells use repair and detoxification pathways
as well as surveillance mechanisms, called checkpoints, which serve to detect the problem and
coordinate repair with chromosome segregation and progression through the cell cycle (see
Figure 3. www.genomic-instability.org/).
Maintaining genomic stability in the face of replication and recombination requires a huge
variety of different damage response proteins. A cell’s ability to decide when and where to
deploy this DNA repair kit is critical to prevent tumor development [11].
There is evidence that inappropriate nutrient supply can cause sizeable levels of genome
mutation and alter expression of genes required for genome maintenance. Deficiencies in
several micronutrients have been shown to cause DNA damage and are thought to be
associated with a number of serious human diseases: folic acid, niacin, vitamin B6 and B12
deficiency may increase the risk of colon cancer, heart disease and neurological dysfunction
due to chromosome breaks and disabled DNA repair [12]. On the other hand, as seen in
reference [13], the authors believe that caloric restriction (CR) is an ‘intervention’ that alters
the activation of specific ‘stress response genes’, key enzymes in DNA repair pathways, which
then results in upregulation of ‘DNA repair’ capacity. Enhanced DNA repair reduces the levels
of DNA damage, consequently reducing mutation frequency, which would result in mainte‐
nance of genomic stability.
Recommended dietary allowances (RDAs) of micronutrients have been traditionally defined
as those levels necessary to prevent symptoms of deficiency diseases. There is increasing
evidence that higher levels of many such micronutrients may be necessary for various DNA
maintenance reactions, and that the current RDAs for some micronutrients may be inadequate
to protect against genomic instability. Dietary imbalance may increase gene mutation and
chromosome aberrations in human populations, similar to exposure to radiation, mutagens
and carcinogens. Diet may well be a key factor in determining genomic stability since it impacts
on all relevant pathways, i.e. exposure to dietary carcinogens, activation/detoxification of
carcinogens, DNA repair, DNA synthesis and apoptosis, as mentioned previously. Many
micronutrient minerals and vitamins act as substrates and/or co-factors in key DNA mainte‐
nance reactions, and the exact concentration of these in the cell may be critical. Sub-optimal
levels of key micronutrients required for DNA maintenance will reduce genomic stability,
producing similar effects to inherited genetic disorders or exposure to carcinogens [14].
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3. Diet and cancer prevention
Current cancer models comprise those that are inherited through the germline and represent
only ∼5% of total cases of human cancers. These tumors originate because of mutational events.
The remaining ∼95% originate as sporadic events and evolve as a result of exposure to the
environment, which includes exposure to both environmental contaminants and dietary
agents. The multistage model of carcinogenesis identifies various phases, initiation, promo‐
tion, and progression, appears to be influenced by tissue microenvironment and organization.
Significant opportunities in nutrition and cancer prevention exist in the early stages of
initiation and promotion prior to clonal expansion of heterogeneous populations. Nutrige‐
nomics represents a strategy that can be applied to the study and prevention of many diseases
including cancer. DNA methylation and histone modifications are epigenetic events that
mediate heritable changes in gene expression and chromatin organization in the absence of
changes in the DNA sequence. The age-increased susceptibility to cancer may derive from
accumulation of epigenetic changes and represents a potential target for therapies with
bioactive compounds. Factors that mediate the response to dietary factors include nuclear
receptors and transcription factors, which function as sensors to dietary components and
determine changes in the profile of transcripts [15]. Milner and Romagnolo [15] affirm that the
opportunity of targeting nutrients–gene interactions to influence the cancer process is modu‐
lated by genetic variations in human populations, epigenetic modifications that selectively and
permanently alter gene expression, by complex interactions/associations among dietary
components, and heterogeneity of cells within a certain tumor. Therefore, integration of
information about gene polymorphisms, identification of gene targets that regulate cell and
Figure 3. A general view of DNA insults and consequences on cell cycle and DNA repair (www.genomic-instabili‐
ty.org/).
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tissue specific pathways, and development of diagnostic strategies to control for clinical
heterogeneity are important to understand how nutrigenomics may be used in cancer
prevention.
Berrino, Krogh and Riboli [16] were made a review which showed an epidemiology studies
on diet and cancer (see Table 2 that summarizes the results of the randomized studies pub‐
lished). The authors summarized (Table 3) the results of the World Cancer Research Fund
(WCRF) evaluation on major foods and nutrients and major cancer sites. The ‘probable’ and
‘possible’ judgements provide a frame of hypotheses to be addressed in further studies. The
overall pattern indicates that vegetarian food, except sugar and alcoholic beverages, is usually
associated with cancer prevention, whereas animal food is frequently associated with cancer
risk. The first WCRF dietary recommendation to reduce cancer, indeed, is: “Choose predom‐
inantly plant-based diets rich in a variety of vegetables and fruits, pulses (legumes) and
minimally processed starchy staple foods”. This seems to open a new perspective in nutrition
and cancer research: from chemoprevention studies based on a single or a few micronutrients
to an experimental strategy requiring a comprehensive modification of dietary habits.
Study and year of
publication Agent Primary end point Relative risk
Relative risk for
secondary end points
ECPOS, 2000 Ispaghula fiber Colon adenoma 1.67**
APPP, 1995 Beta-carotene Colon adenoma 1.50**
CARET, 1996 Beta-carotene Lung cancer 1.28**
APPP, 1995 Cereal fibre Colon adenoma 1.20
TPPT, 1994 Cereal fibre* Colon adenoma 1.20
ATBC, 1994 Beta-carotene Lung cancer 1.18** 0.98 for colonadenoma
1.05 for colorectal
cancer
1.26 for stomach
cancer
1.23 for prostate
cancer
NPCS, 1996 Selenium Skin, squamous cell 1.14 0.50** for all cancers
NPCS, 1996 Selenium Skin, basal cell 1.10
PPS, 1994 Vit C + Vit E Colon adenoma 1.08
SWCPS, 1997 Retinol Skin, basal cell 1.06
Linxian, China, 1993 Vit C + Mb All cancers 1.06 1.10 for stomachcancer
SCPS, 1990 Beta-carotene Skin 1.05
PPS, 1994 Beta-carotene Colon adenoma 1.01
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Study and year of
publication Agent Primary end point Relative risk
Relative risk for
secondary end points
Linxian, China, 1993 Retinol + Zn All cancers 1.00 0.96 for stomachcancer
EUROSCAN, 2000 Retinilpalmitate Lung cancer 1.00
Alberts et al., 2000 Cereal fiber Colon adenoma 0.99
ATBC, 1994 Alpha tocopherol Lung cancer 0.99 0.64** for prostatecancer
1.66** for colon
adenoma
0.83 for colorectal
cancer
1.26 for stomach
cancer
1.18** for stomach
cancer
Linxian, China, 1993 14 vitamins + 12minerals*** Esophagus/cardias 0.98
PHS, 1996 Beta-carotene All cancers 0.98 0.95 for lung cancer
Linxian, China, 1993 Riboflavin+niacin All cancers 0.95 1.04 for stomachcancer
Linxian, China, 1993 Se + Vit E + beta-carotene All cancers 0.93
0.79** for stomach
cancer
0.91** for total
mortality
Baron et al., 1999 Calcium Colon adenoma 0.83
SWCPS, 1997 Retinol Skin, squamous cell 0.74**
ECPOS, 2000 Calcium Colon adenoma 0.66
*and low fat diet; **P < 0.05; ***including selenium, vitamin E and beta-carotene.
APPP, Australian Polyp Prevention Project; ATBC, Alpha Tocopherol Beta Carotene study; CARET, Carotene and Retinol
Efficacy Trial; ECPOS, European Cancer Prevention Organisation Study Group; EUROSCAN, European Organization for
Research and Treatment of Head and Neck Cancer and Lung Cancer Cooperative Group; NPCS, Nutritional Prevention
of Skin Cancer; PHS, Physicians Health Study; PPS, Polyp Prevention Study Group; PPT, Polyp Prevention Trial; SCPS, Skin
Cancer Prevention Study Group; SWCPS, Sothwest Skin Cancer Prevention Study; TPPT, Toronto Polyp Prevention Trial.
Adapted from reference [16].
Table 2. Randomized controlled trials of dietary supplements to prevent cancer or colorectal adenomas, ordered by
relative risk
American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention
[17] says that many epidemiologic studies have reported a modest but significant association
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between high intakes of processed meats (such as bacon, sausage, luncheon meats) and red
meats (defined as beef, pork, or lamb) and increases in cancer incidence and mortality as well
as death from other causes. The American Cancer Society says that current evidence supports
approximately a 15% to 20% increased risk of cancers of the colon and/or rectum per 100 grams
(g) of red meat or 50 g of processed meat consumed per day, while the evidence for some other
cancers (those of the esophagus, stomach, lung, pancreas, breast, prostate, stomach, endome‐
trium, renal, and ovarian) is considered limited and suggestive. According to American Cancer
Society meat contains several constituents that could increase the risk of cancer. Mutagens and
carcinogens (heterocyclic amines and polycyclic aromatic hydrocarbons) are produced by
cooking meat at high temperatures and/or by charcoal grilling. Nitrates/nitrites and salt used
to process meat contribute to the formation of nitrosamines, which are known mutagens and
carcinogens in animals. Iron from the heme group of myoglobin in red meat may act as a
catalyst to nitrosamine formation, and generate free radicals that may damage DNA. It is also
Vegetables Fruits Grains,fibers Tea Sugar Alcohol
Salt &
salting Meat Eggs
Milk &
dairy
Mouth, pharynx – – – – – – +++
Nasopharynx +++
Esophagus – – – – – – + +++
Stomach – – – – – – – – ++
Pancreas – – – – – +
Gallbladder
Liver – +++
Colon, rectum – – – – ++ +
Larynx – – – – +++
Lung – – – – – – +
Breast – – – – – ++ +
Cervix – –
Endometrium – –
Ovary – –
Prostate – + +
Bladder – – – –
Kidney – + +
Thyroid –
Increased risk: +++, convincing; ++, probable; +, possible; decreased risk: – – –, convincing; – –, probable; –, possible. Data
adapted from reference [16].
Table 3. Matrix summary of the WCRF/AICR judgments on the role of various foods in the risk of cancer
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possible that the fat content in meat contributes to risk through increasing the concentration
of secondary bile acids and other compounds in the stool that could be carcinogens or
promoters of carcinogenesis [17].
According to Davis [18] epidemiologic evidence suggests that regular consumption of fruits,
vegetables, and whole grains may reduce cancer risk in some individuals. This association has
been attributed to these foods being rich sources of numerous bioactive compounds. Plant
foods contain a variety of components, including, but not limited to, essential nutrients,
polyunsaturated fatty acids, and phytochemicals such as glucosinolates and flavonoids, many
of which can inhibit cell proliferation and induce apoptosis, and which may act additively or
synergistically when combined in the human diet.
3.1. Polyphenols
Polyphenols are common constituents of foods of plant origin and major antioxidants of our
diet. The main dietary sources of polyphenols are fruits and beverages. Fruits like apple, grape,
pear, cherry, and various berries contain up to 200–300 mg polyphenols per 100 g fresh weight.
Typically, a glass of red wine or a cup of tea or coffee contains about 100 mg polyphenols.
Cereals, chocolate, and dry legumes also contribute to the polyphenol intake [19]. Red wine
polyphenols, which consisted of various powerful antioxidants such as flavonoids and
stilbenes, have been implicated in cancer prevention and that promote human health without
recognizable side effects. Experimental studies have shown that polyphenols from red wine,
like resveratrol, quercetin, (+)-catechin and gallic acid, were potential cancer chemopreventive
agents. However, red wine contains a wide range of different polyphenols and protective
effects have not been assigned to a specific fraction or compound, so it is not yet clear which
compounds present in red wine are endowed with protective activity [20]. Among the most
highly cited class of polyphenols are the flavonoids, which comprise a large and diverse family
of compounds synthesized by plants. Flavonoid subclasses include anthocyanidins in berries
and grapes, flavanols in tea, flavanones in citrus fruits, flavonols in onions, flavones in herbs
and peppers, and isoflavones in soy [21].
Zhou et al. [22] evaluated combined effects of soy phytochemical concentrate (SPC) and tea
(green tea and black tea) components on the growth and metastasis of androgen-sensitive
LNCaP human prostate cancer. The authors find that both black tea and green tea inhibited
tumorigenicity rates of LNCaP tumors. For them the combination of soy phytochemicals and
tea synergistically inhibited tumorigenicity, final tumor weight and metastasis to lymph nodes
in vivo. This study supports further investigations using soy and tea combinations as effective
nutritional regimens for prevention of prostate cancer. According to authors, studies of tea
polyphenols suggest that epigallocatechin gallate (EGCG) is the major bioactive component
in green tea and less is present in black tea. Black tea also contains other tea polyphenols such
as theaflavins and thearubigins. They also affirm that chemopreventive properties of the soy
isoflavone genistein have been the subject of extensive in vitro and in vivo.
Lambert and Yang [23] affirm that although numerous health benefits have been proposed for
the consumption of tea, the effectiveness of tea as a cancer preventive agent in humans remains
unclear. Animal models of carcinogenesis may be different from the human situation (e.g., the
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doses of tea and tea components used in animal studies are often much higher than those
consumed by humans), and many confounding factors are involved in epidemiological
studies. Interindividual variation in biotransformation and bioavailability may also affect the
efficacy of tea as a cancer preventive agent. For them further studies on definitive mechanisms
of cancer preventive activities of tea in animal models are needed. Although many possible
mechanisms have been proposed, their relevance in vivo needs to be demonstrated. With some
exceptions, the concentrations of catechins or theaflavins used in cell culture systems exceed
the plasma concentrations obtained in animal studies by 10- to 100-fold. Mechanisms based
on the use of such high concentrations may be relevant for cancers of the gastrointestinal tract
but not for sites such as the lung, prostate and breast, which depend on systemic bioavailability.
In spite of many in vitro and in vivo studies, the molecular mechanisms for the cancer
preventive actions of these compounds are not clearly known. The relationship between tea
consumption and cancer risk has not been conclusively demonstrated, and the relationship
may become clearer if we consider the effects of specific types of tea, at defined doses, in
populations with certain dietary patterns or genetic polymorphisms. Human intervention
trials and large prospective studies are needed to further assess cancer preventive activities of
tea constituents [24]. For the National Cancer Institute [25] more than 50 epidemiologic studies
of the association between tea consumption and cancer risk have been published since 2006.
The results of these studies have often been inconsistent, but some have linked tea consump‐
tion to reduced risks of cancers of the colon, breast, ovary, prostate, and lung. They also believe
that the inconsistent results may be due to variables such as differences in tea preparation and
consumption, the types of tea studied (green, black, or both), the methods of tea production,
the bioavailability of tea compounds, genetic variation in how people respond to tea con‐
sumption, the concomitant use of tobacco and alcohol, and other lifestyle factors that may
influence a person’s risk of developing cancer, such as physical activity or weight status.
A double-blind intervention trial conducted in patients with oral mucosa leukoplakia using a
mixed tea showed some direct evidence on the protective effects of tea on oral cancer. In this
study developed by Li et al. [26] fifty-nine oral mucosa leukoplakia patients, diagnosed by
established clinical and pathological criteria, were randomly divided into a treated group (3 g
mixed tea oral administration and topical treatment) and a control group (placebo and glycerin
treatment). After the 6-month trial, the size of oral lesion was decreased in 37.9% of the 29
treated patients and increased in 3.4%; whereas the oral lesion was decreased in 10.0% of the
30 control patients and increased in 6.7%.
3.2. Vitamins and micronutrients
Natural inhibitors of oxidizing agents that are found in the diet are important in preventing
cancer and typically do not have the undesirable side effects of many xenobiotic compounds.
Some vitamins, such as the antioxidant Vitamins A, E, and C, demonstrate these protective
effects. The daily ingestion of antioxidants has the potential of not only protecting against
cancer, but also cardiovascular disorders and neurological degenerative diseases [28]. Anti‐
oxidants nutrients such as vitamin E, vitamin C, vitamin A, and Beta-carotene are involved in
detoxification of the Reactive oxygen species (ROS). Vitamin E, A, and Beta-carotene are
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lipophilic antioxidants whereas vitamin C is hydrophilic antioxidant. Vitamin E function as a
free radical chain breaker particularly it interferes with the propagation step of lipid peroxi‐
dation. Vitamin A and Beta-carotene have actions by quenching both singlet oxygen and other
free radicals generated by photochemical reactions [28].
The changes in the DNA by a deficiency of some micronutrients (folic acid, vitamin B12,
vitamin B6, niacin, vitamin C, vitamin E, iron and zinc) are considered as the most likely cause
of some types of cancer [29].
Studies  investigating  the  interactions  between  dietary  exposure  and  genetic  polymor‐
phisms have the potential to clarify mechanisms and identify susceptible subgroups so that
preventative strategies can be focused on the subgroups for maximum benefit. Red meat
or meat cooking methods such as frying and doneness levels have been associated with the
increased risk of  colorectal  and other cancers [30].  It  is  not clear whether it  is  red meat
intake or the way meat is cooked that is involved in the etiology of colorectal cancer, as
stated above.  Both  cooking methods  and doneness  level  of  red meat  are  thought  to  be
surrogates for heterocyclic amines (HCA) consumption [31]. Sinha and Caporaso [31] affirm
that genetics polymorphisms may interact with various dietary components and thus define
subgroups of individuals who may be at a higher risk of getting cancer. For them there are
also other polymorphic enzymes that may interact with various dietary components and
play a role in human carcinogenesis. The authors describe categories of susceptibility genes,
potential dietary carcinogens and anticarcinogens, and cancer sites in which they may be
involved  (see  Table  4).  Many  studies  are  currently  investigating  the  role  of  circulating
vitamin D metabolites and dietary calcium. Because the vitamin D receptor is involved in
vitamin D and calcium metabolism, the vitamin D receptor polymorphisms may also be
important for colorectal cancers. Martinez et al. [32] investigated the associations between
the intake of calcium and vitamin D and the occurrence of colorectal cancer. They found
that vitamin D is suggestive of an inverse association, particularly for total vitamin D in
relation to rectal cancer. However, since most of the support for this protective effect was
seen for total vitamin D. They not rule out the possibility that something other than vitamin
D in multivitamin supplements contributes to this apparent effect.  The relation between
vitamin D and colorectal cancer may be better elucidated with additional dietary measure‐
ments and further follow-up. They conclude that available evidence does not warrant an
increase in calcium intake to prevent colon cancer, but longer-term studies of both calcium
and especially vitamin D in relation to colorectal cancer risk are needed.
Carotenoids are the pigments that give fruits and vegetables such as carrots, cantaloupe, sweet
potato, and kale their vibrant orange, yellow, and green colors. Beta-carotene, lycopene, and
lutein are all different varieties of carotenoids. They all act as antioxidants with strong cancer-
fighting properties. Preclinical studies have shown that some carotenoids have potent
antitumor effects both in vitro and in vivo, suggesting potential preventive and/or therapeutic
roles for the compounds. Since chemoprevention is one of the most important strategies in the
control of cancer development, molecular mechanism-based cancer chemoprevention using
carotenoids seems to be an attractive approach [33]. Epidemiologic studies have shown an
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inverse relationship between the presence of various cancers and dietary or blood carotenoid
levels. According to Tanaka, Shnimizu and Moriwaki [33] the epidemiologic observations of
the possible protective effects of high dietary (not supplemental) β-carotene intakes against
cancer, along with what is known about carotenoid biochemical functions, has led to further
study of the effect of β-carotene on cancer risk. Long-term large randomized intervention trials
were designed to test the efficacy of high doses of β-carotene (20–30 mg/day) in the prevention
of cancer. These results are summarized in Table 5.
Dietary component Polymorphicgene/phenotype1 Cancer site
Carcinogens
NAT2, (NAT1), CYP1A2 Colorectal, breast,
Heterocyclic amines (CYP1A1) other sites
Polycyclic hydrocarbons CYP1A1, GSTM1 Gastrointestinal tract Nasophyrangeal,stomach
Nitrosamines CYP2E1
Aflatoxins GSTM1, EPHX Liver
Alcohol ADH (ALDH, CYP2E1) Colorectal, oral
Anticarcinogens
Cruciferous
vegetables CYP1A2, GST
Colorectal, other
sites
Fruits and vegetables CYP1A2, GST Many sites
Calcium/vitamin D Vitamin D receptor Colorectal, prostate
Acute
promylocytic
Leukemia, skin,
Retinoic acid receptor Head and neck,
Retinoids Variant breast
MTHFR, Methionine
Folate, methionine Synthase Colorectal, cervix
1 Abbreviations used: NAT, N-acetyltminsferase; CYP, cytochrome p450; GST, glutathione-S-transferase; EPHX, epoxide
hydrolase; ADH, alcohol dehydrogenase; MTHFR, metheylenetetrahydrofolate reductase. Adapted from reference [31].
Table 4. Polymorphic genes, dietary components and cancer: possible candidates
Cancer Treatment - Conventional and Innovative Approaches404
Figure 4. Proposed mechanisms by which certain carotenoids suppress carcinogenesis. Adapted from reference [33].
Study Designs
Studies Population Intervention Duration Cancer outcome
ATBC
29,133 Finish male
smokers (50–69 years
of age)
β-carotene, 20 mg/day;
vitamin E, 50 mg/day 5–8 years
18% increase in lung
cancer; 8% increase in
mortality
CARET
18,314 men and women
and asbestoss workers
(45–74 years of age)
β-carotene, 30 mg/day;
vitamin A, 25,000 IU <4 years
28% increase in lung
cancer; 17% increase in
deaths
PHS 22,071 male physicians(40–84 years of age)
β-carotene, 50 mg on
alternate days 12 years
No effect of supplementation
in
incidence of cancer
Linxian
29,584 men and
women, vitamin and
mineral deficient
(40–69 years of age)
β-carotene, 15 mg/day;
selenium, 50 mg/day;
α-tocopherol,
30 mg/day
5 years
13% decrease in total
cancers; 9% decrease in
overall deaths
Women’s
Health
Study
39,876 female health
professionals (over
45 years of age)
β-carotene, 50 mg on
alternate days
4.1 years (2.1
years’ treatment
and 2.0 years’
follow-up)
No effect of
supplementation in
incidence of cancer
Data adapted from reference [33].
CARET, Beta-Carotene and Retinol Efficacy Trial; ATBC, Alpha Tocopherol and Beta-Carotene Cancer Prevention; PHS,
Physicians’ Health Study.
Table 5. β-Carotene supplementation trials.
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The authors [33] wrote an important review which showed a table (Table 6) about cancer
prevention by means of carotenoids with dietary sources, function e effects. According to these
authors the mechanisms underlying the anticancer and/or cancer chemopreventive activities
of carotenoids may involve changes in pathways leading to cell growth or cell death. These
include immune modulation, hormone and growth factor signaling, regulatory mechanisms
of cell cycle progression, cell differentiation and apoptosis. In this sense the authors also
showed an interesting figure proposing possible mechanisms by which certain carotenoids
suppress carcinogenesis (see Figure 4 on the left).
Studies involving the use of vitamin C in cancer prevention are the most contradictory. Vitamin
C is an essential vitamin the human body needs to function well. It is a water-soluble vitamin
that cannot be made by the body, and must be obtained from foods or other sources. Vitamin
C is found in abundance in citrus fruits such as oranges, grapefruit, and lemons, and in green
leafy vegetables, potatoes, strawberries, bell peppers, and cantaloupe. American Cancer
Society [34] wrote that many studies have shown a connection between eating foods rich in
vitamin C, such as fruits and vegetables, and a reduced risk of cancer. On the other hand,
evidence indicates that vitamin C supplements do not reduce cancer risk. This suggests that
the activity of fruits and vegetables in preventing cancer is due to a combination of many
vitamins and other phytochemicals and not to vitamin C alone. Clinical trials of high doses
vitamin C as a treatment for cancer have not shown any benefit. High doses of vitamin C can
cause a number of side effects.
According to Block [35] epidemiologic evidence of a protective effect of vitamin C for non-
hormone-dependent cancers is strong. Of the 46 such studies in which a dietary vitamin C
index was calculated, 33 found statistically significant protection, with high intake conferring
approximately a twofold protective effect compared with low intake. 0f 29 additional studies
that assessed fruit intake, 2 1 found significant protection. For cancers of the esophagus, larynx,
oral cavity, and pancreas, evidence for a protective effect of vitamin C or some component in
fruit is strong and consistent. For cancers of the stomach, rectum, breast, and cervix there is
also strong evidence. Several recent lung cancer studies found significant protective effects of
vitamin C or of foods that are better sources of vitamin C than of /3-carotene. It is likely that
ascorbic acid, carotenoids, and other factors in fruits and vegetables act jointly.
Several lines of evidence suggest that vitamin C is a powerful antioxidant in biological systems
in vitro. However, its antioxidant role in humans has not been supported by currently available
clinical studies. Diets high in fruits and vegetables protect against cardiovascular disease and
cancer, but such a protective effect cannot as yet be ascribed to vitamin C. In vivo markers of
oxidative damage are being developed, and these have yet not shown major changes with
vitamin C intake in humans [36]. The most important problem about vitamin C is that it can
exert a pro-oxidant activity under certain conditions, particularly in the presence of transition
metal ions or alkali. Thus, vitamin C in vitro reduces free ferric iron that generates hydrogen
peroxide in the Fenton reaction and results in the production of hydroxyl radicals. The reactive
hydroxyl radical quickly reacts with critical cellular macromolecules, including DNA, which
may lead to mutagenesis and the initiation of cancer [37]. According to authors, the high
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Carotenoids Dietary Sources Function Effects
α-Carotene
Yellow-orange vegetables
(carrots, sweet totatoes,
pumpkin) and Dark-green
vegetables (broccoli, green
beans, spinach)
Provitamin A activity;
Anti-oxidant
Immune- enhancement; Stimulate
cell to cell communication;
Decreases risk of some cancers
β-Carotene
Green leafy vegetables and
orange and yellow fruits and
vegetables (carrots, apricots,
spinach, sweet potetoes,
pumpkin, pepper, kale,
cantaloupe)
Provitamin A activity;
Antioxidant
Immune-enhancement; Decreases
risk of some cancers and some
cardiovascular events; high-dose
supplementation may increase the
risk of lung cancer among smokers
Lycopene Tomatoes, water melon,apricot, peaches Anti-oxidant
Decreases risk of some cancers and
some cardiovascular events,
diabetes, and osteoporosis
β-Cyptoxanthin
Orange fruits (mandarin
orange and papaya, etc.),
corn, peas, and egg yolks
Provitamin A activity;
Anti-oxidant
Anti-inflammatory effects; Inhibits
risks of some cancer and
cardiovascular events; Immune
enhancemen
Lutein/Zeaxanthin
Dark green leafy vegetables
(spinach, kale), red peppers,
maize, tomatoes, corn, and
egg yolks
Anti-photosensitizing
agent and
photosynthetic
pigment; Acts as
antioxidants and blue
light filters
Decrease age-related macular
degeneration, cataract, and risk of
cardiovascular disease and certain
cancers
Astaxanthin Green algae, salmon, trout,Crustacean Antioxidant; Coloration
Prevent certain cancers, cataract,
diabetes, and inflammatory
neurodegenerative and
cardiovascular diseases
Canthaxanthin Salmon, crustacean Antioxidant; Coloration Immune enhancement; Decreasesrisk of some cancers
Focoxanthin Brown algae, heterokonts Antioxidant
Anti-cancer, anti-allergic, anti-obese,
anti-inflammatory, and
anti-osteoporotic activities
Adapted from reference [33].
Table 6. Sources, function, and effects of different carotenoids.
Nutrigenomics and Cancer Prevention
http://dx.doi.org/10.5772/55429
407
consumption of vitamin C–rich fruit and vegetables is not likely to be harmful. In general, data
from in vitro and in vivo experiments and population-based studies do not indicate that high
doses of vitamin C are linked to increased oxidative DNA damage or an elevated risk of cancer.
Lee et al. [37] believe that the cancer preventive effects of vegetables and fruit may result from
multiple combined effects of various phenolic phytochemicals, vitamins, dietary fibers,
indoles, allium compounds, and selenium rather than from the effect of a single active
ingredient. For them, many dietary phenolic phytochemicals may have stronger antioxidant
and antitumor promotion effects than do antioxidant vitamins, which may contribute to the
chemopreventive effects of the phytochemicals in carcinogenesis. However, these authors
suggest that the chemopreventive effects of vitamin C in carcinogenesis may be linked to the
protective effects of vitamin C against epigenetic mechanisms, such as the inflammation and
inhibition of gap junction intercellular communication (GJIC), as well as to antioxidant
activities (see Figure 5).
Figure 5. Possible chemopreventive mechanisms of vitamin C in carcinogenesis. ROIs, reactive oxygen intermediates;
GPx, glutathione peroxidase; GST, glutathione S-transferase; QR, quinone oxidoreductase; SOD, superoxide dismutase;
CAT, catalase. Adapted from reference [37].
Regarding the use of vitamin C in cancer patient the results were not promising. In a double-
blind study 100 patients with advanced colorectal cancer were randomly assigned to treatment
with either high-dose vitamin C (10 g daily) or placebo. Overall, these patients were in very
good general condition, with minimal symptoms. None had received any previous treatment
with cytotoxic drugs. Vitamin C therapy showed no advantage over placebo therapy with
regard to either the interval between the beginning of treatment and disease progression or
patient survival. Among patients with measurable disease, none had objective improvement.
On the basis of this and our previous randomized study, it can be concluded that high-dose
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vitamin C therapy is not effective against advanced malignant disease regardless of whether
the patient has had any prior chemotherapy [38].
The terms folic acid and folate are often used interchangeably for this water-soluble B-complex
vitamin. Folic acid, the more stable form, occurs rarely in foods or the human body but is the
form most often used in vitamin supplements and fortified foods. Folic acid is essential to
numerous bodily functions ranging from nucleotide biosynthesis to the remethylation of
homocysteine. The human body needs folate to synthesize DNA, repair DNA, and methylate
DNA as well as to act as a cofactor in biological reactions involving folate.
Considerable epidemiological evidence suggests that a low-folate diet is associated with an
increased risk of colorectal neoplasia. Much animal data support an antineoplastic effect of
folate. However, in some animal studies, folate deficiency protects against, and supplemen‐
tation increases, experimental carcinogenesis. Cole et al. [39] developed a double-blind,
placebo-controlled, 2-factor, phase 3, randomized clinical trial conducted at 9 clinical centers
between July 6, 1994, and October 1, 2004. Participants included 1021 men and women with a
recent history of colorectal adenomas and no previous invasive large intestine carcinoma.
Participants were randomly assigned in a 1:1 ratio to receive 1 mg/d of folic acid (n=516) or
placebo (n=505), and were separately randomized to receive aspirin (81 or 325 mg/d) or
placebo. Follow-up consisted of 2 colonoscopic surveillance cycles (the first interval was at 3
years and the second at 3 or 5 years later). In this double-blind, placebo-controlled, randomized
clinical trial, was found that folic acid supplementation did not decrease the risk of adenoma
occurrence among participants with a recent history of adenomas. The authors concluded that
folate, when administered as folic acid for up to 6 years, does not decrease the risk of adenoma
formation in the large intestine among individuals with previously removed adenomas. For
them, the evidence for an increased risk of adenomas is equivocal and requires further research.
In March of 1996, the U.S. Food and Drug Administration mandated that all enriched flour
and uncooked cereal grains sold in the United States should be fortified with 140 µg folic acid/
100 g of flour no later than January of 1998. Following the institution of fortification population-
based studies showed the effectiveness of this measure: plasma levels of folate in the adult
population increased ~2-fold as a result and the incidence of births complicated by neural tube
defects was variously reported to decline by 20% to 50%. However, analyses of several cereal
grains that were purchased after the institution of fortification showed that in many instances
the actual amount of folate was 150% to 300% greater than the mandate, suggesting that in this
early era of fortification, manufacturers often included ‘‘overage’’ to ensure that they were
meeting the minimal level of mandated fortification [40]. Thus, the authors hypothesize, by
means of an epidemiological study, that the institution of folic acid fortification may have been
wholly or partly responsible for the observed increase in colorectal cancer rates in the
mid-1990s. The authors affirm that wish to highlight the potential complexity of the response
to this nutrient and emphasize prior observations that have been made in both preclinical and
clinical studies that indicate that administering high doses of folic acid to susceptible individ‐
uals or in an inappropriate time frame may accelerate the growth of existing neoplasms.
Vitamin C, also known as ascorbic acid, is a water-soluble vitamin. Unlike most mammals and
other animals, humans do not have the ability to make their own vitamin C. Therefore, we
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must obtain vitamin C through our diet. Vitamin C is required for the synthesis of collagen,
an important structural component of blood vessels, tendons, ligaments, and bone. Vitamin C
also plays an important role in the synthesis of the neurotransmitter, norepinephrine. Neuro‐
transmitters are critical to brain function and are known to affect mood. Vitamin C is also a
highly effective antioxidant. Even in small amounts vitamin C can protect indispensable
molecules in the body, such as proteins, lipids (fats), carbohydrates, and nucleic acids (DNA
and RNA), from damage by free radicals and reactive oxygen species that can be generated
during normal metabolism as well as through exposure to toxins and pollutants (e.g., cigarette
smoke). In the U.S., the recommended dietary allowance (RDA) for vitamin C was revised in
2000 upward from the previous recommendation of 60 mg daily for men and women. The
RDA continues to be based primarily on the prevention of deficiency disease, rather than the
prevention of chronic disease and the promotion of optimum health. The recommended intake
for smokers is 35 mg/day higher than for non-smokers, because smokers are under increased
oxidative stress from the toxins in cigarette smoke and generally have lower blood levels of
vitamin C (see Table 7 – reference [41]).
Life Stage Age Males (mg/day) Females (mg/day)
Infants 0-6 months 40 (AI) 40 (AI)
Infants 7-12 months 50 (AI) 50 (AI)
Children 1-3 years 15 15
Children 4-8 years 25 25
Children 9-13 years 45 45
Adolescents 14-18 years 75 65
Adults 19 years and older 90 75
Smokers 19 years and older 125 110
Pregnancy 18 years and younger - 80
Pregnancy 19 years and older - 85
Breast-feeding 18 years and younger - 115
Breast-feeding 19 years and older - 120
Data from reference [41].
Table 7. Recommended Dietary Allowance (RDA) for Vitamin C
The relations between the intake of beta-carotene, vitamin C, selenium, and 25-yr mortality
from lung cancer and total cancer were analyzed within the Zutphen Study, a cohort study on
diet and chronic diseases [42]. The Zutphen Study is a prospective study on the relations
between diet, other risk factors, and the incidence of chronic diseases. The results of this study
suggest that vitamin C intake may be more important for prevention of lung cancer than beta-
carotene. It can, however, not be ruled out that substances present in fruit other than vitamin
C (eg, phenols, flavones, and terpenes) may also be of importance in lung cancer prevention.
The results suggest that a vitamin C intake of ≥ 70 mg/d may be of importance in lung cancer
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prevention. Due to the role of vitamin C in the formation of N-nitrosocompounds, this may
also be of importance for stomach cancer prevention. Another hand, 8 prospective studies does
not suggest that intakes of vitamins A, C and E and folate reduce the risk of lung cancer. The
results were similar with different analytic approaches and across studies, sex, smoking status
and lung cancer cell type [43].
Data on intake of specific carotenoids and breast cancer risk are limited. Furthermore, studies
of vitamins A, C, and E in relation to breast cancer risk are inconclusive. Zhang et al. [44] were
made studies, using multivariate analysis, demonstrated associations between intakes of
specific carotenoids, vitamins A, C, and E, consumption of fruits and vegetables, and breast
cancer risk in a cohort of 83,234 women (aged 33-60 years in 1980). Through 1994, they
identified 2,697 incident cases of invasive breast cancer (784 premenopausal and 1913 post‐
menopausal). The results demonstrated that intakes of beta-carotene from food and supple‐
ments, lutein/zeaxanthin, and vitamin A from foods were weakly inversely associated with
breast cancer risk in premenopausal women. Strong inverse associations were found for
increasing quintiles of alpha-carotene, beta-carotene, lutein/zeaxanthin, total vitamin C from
foods, and total vitamin A among premenopausal women with a positive family history of
breast cancer. An inverse association was also found for increasing quintiles of beta-carotene
among premenopausal women who consumed 15 g or more of alcohol per day. Premenopausal
women who consumed five or more servings per day of fruits and vegetables had modestly
lower risk of breast cancer than those who had less than two servings per day (relative risk
[RR] = 0.77; 95% confidence interval [CI] = 0.58-1.02); this association was stronger among
premenopausal women who had a positive family history of breast cancer (RR = 0.29; 95% CI
= 0.13-0.62) or those who consumed 15 g or more of alcohol per day (RR = 0.53; 95% CI =
0.27-1.04). The author concluded that consumption of fruits and vegetables high in specific
carotenoids and vitamins may reduce premenopausal breast cancer risk [44].
In recent years, the intake of vitamins, minerals and herbs as a dietary supplement has
increased dramatically. The supplementation with vitamins and minerals are used more often
than the herbs. The most common supplements among users in the U.S. are multivitamins
(75%), followed by vitamin C (38%), and iron (38%) [45]. Food supplementation with vitamins
is a polemic question and it differs among authors. There are evidences that dietary supple‐
mentation with vitamin C may reduce the incidence of gastric cancer in certain populations,
but it is unclear whether it was the antioxidant, vitamin or other property, responsible for this
action [46]. However, the author states that it does not justify, in terms of cancer prevention to
make a diet supplemented with vitamin C if the person has a good diet. Claycombe and
Meydani [47] were made a review reporting the protective effect of vitamin E against chro‐
mosomal alterations induced by oxidation of DNA. However, the authors call attention to the
careful supplementation, simultaneous with C vitamin E, considering a possible genotoxicity
in the association of the two vitamins. Although most animal studies have shown cancer-
preventive effects, a few recent studies suggest that soy phytoestrogens may stimulate breast
cancer cell growth under certain circumstances. Before recommendations regarding phytoes‐
trogen supplements can be safely made, we must have more information on the effects of the
extracts on bone, heart and breast health. Until safety with respect to breast cancer is estab‐
lished, phytoestrogen supplements should not be recommended, particularly for women at
high risk of breast cancer [48].
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Cancer prevention can be done with a diet rich in vegetables, fruits, and low in red meat,
saturated fats, salt and sugar. Carbohydrates should be consumed in the form of cereals - wheat
bread and brown rice. The addition of fats should be in the form of fats dehydrogenated [49].
The types of vegetables or fruit that most often appear to be protective against cancer are allium
vegetables, carrots, green vegetables, cruciferous vegetables, and tomatoes. Substances present
in some vegetable and fruit may help cancer prevention and they include dithiolthiones,
isothiocyanates, indole-3-carbinol, allium compounds, isoflavones, protease inhibitors,
saponins, phytosterols, inositol hexaphosphate, vitamin C, D-limonene, lutein, folic acid, beta
carotene, lycopene, selenium, vitamin E, flavonoids, and dietary fiber. Current US vegetable
and fruit intake, which averages about 3.4 servings per day, is discussed, as are possible non-
cancer-related effects of increased vegetable and fruit consumption, including benefits against
cardiovascular disease, diabetes, stroke, obesity, diverticulosis, and cataracts [50].
4. Conclusion
Cancer incidence is projected to increase in the future and an effectual preventive strategy is
required to face this challenge. Alteration of dietary habits is potentially an effective approach
for reducing cancer risk. Assessment of biological effects of a specific food or bioactive
component that is linked to cancer and prediction of individual susceptibility as a function of
nutrient-nutrient interactions and genetics is an essential element to evaluate the beneficiaries
of dietary interventions [51]. We know that diet is an important factor both to minimize, as to
increase the risk of cancer development. But diet is not the only factor. There are several risk
factors that can trigger a process of tumor formation. Sedentary life, environmental issues,
viruses, smoking, alcohol in excess, are factors that contribute to and are also strategic points
that should be worked in cancer prevention.
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